Skip to main content
OpenTrials

Clinical trial condition

Herpesviridae Infections

Explore clinical trials studying Herpesviridae Infections. Study availability and eligibility vary by location and protocol.

1,824 public trials 252 recruiting studies
Refine in advanced search Browse all conditions

Herpesviridae Infections trial results

Completed

Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts

NCT03160079

Conditions
B-Cell Acute Lymphoblastic Leukemia, Adult, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations
  • UCSF Fresno Community Cancer Institute Clovis, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UC Irvine Health Chao Family Comprehensive Cancer Center Orange, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
View Trial Details
Completed

Treatment of Older Patients With B-precursor ALL With Sequential Dose Reduced Chemotherapy and Blinatumomab

NCT03480438

Conditions
B-precursor ALL, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • University Hospital of Frankfurt (Main) Frankfurt am Main, Hesse, Germany
  • Uniklinik RWTH Aachen Aachen, Germany
  • Charité - Campus Benjamin Franklin Berlin, Germany
  • Vivantes Klinikum Neukölln Berlin, Germany
View all 21 locations
View Trial Details
Completed

Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia

NCT03915366

Conditions
Acquired Immunodeficiency Syndrome, Actinomycetales Infections, Bacterial Infections, +27 more
Locations
  • Programme PACCI. Centre Hospitalier Cocody. Abidjan, Côte d’Ivoire
  • Université de Bourdeaux Bourdeaux, France
  • INSERM Toulouse, France
  • PENTA Foundation Padova, Italy
View all 13 locations
View Trial Details
Completed

A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes

NCT05298254

Conditions
Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +17 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Wichita, Kansas, United States
  • GSK Investigational Site Kansas City, Missouri, United States
  • GSK Investigational Site Rochester, New York, United States
View all 30 locations
View Trial Details

Related conditions